Granules India Ltd

Granules India Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Granules India Ltd

₹ 592 -1.27%
20 Dec - close price
granulesindia.com BSE: 532482 NSE: GRANULES
About

Granules India Ltd and its subsidiaries are primarily involved in the manufacturing and selling of Active Pharma Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs) and Finished Dosages.[1]

Key Points

Business Segments

Website BSE NSE
  • Market Cap ₹ 14,365 Cr.
  • Current Price ₹ 592
  • High / Low ₹ 725 / 382
  • Stock P/E 38.3
  • Book Value ₹ 132
  • Dividend Yield 0.25 %
  • ROCE 17.1 %
  • ROE 15.1 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company has reduced debt.

Cons

  • Dividend payout has been low at 8.41% of profits over last 3 years
  • Company has high debtors of 159 days.
  • Promoter holding has decreased over last 3 years: -3.17%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Part of BSE 250 SmallCap Index Nifty Healthcare Index Nifty Total Market Nifty Smallcap 250 Nifty MidSmall Healthcare

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
704 890 913 921 964 1,032 1,014 821 1,009 984 940 852 568
610 698 707 725 778 794 797 664 801 738 751 675 465
Operating Profit 93 192 206 197 186 239 217 157 208 247 189 177 103
OPM % 13% 22% 23% 21% 19% 23% 21% 19% 21% 25% 20% 21% 18%
4 5 4 5 4 -1 3 0 1 1 3 2 3
Interest 4 3 4 4 8 12 14 15 18 20 20 18 15
Depreciation 32 31 32 35 35 38 38 35 36 36 36 36 35
Profit before tax 62 163 175 162 146 188 168 107 156 192 137 126 56
Tax % 25% 25% 26% 23% 25% 25% 25% 25% 26% 26% 29% 25% 26%
46 121 129 125 109 140 125 80 116 143 97 94 41
EPS in Rs 1.86 4.89 5.21 5.03 4.39 5.78 5.18 3.30 4.79 5.89 4.01 3.87 1.71
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
677 990 1,213 1,328 1,349 1,647 2,098 2,310 3,135 3,238 3,931 3,755 3,345
598 826 1,001 1,058 1,054 1,353 1,766 1,816 2,273 2,589 3,092 2,951 2,628
Operating Profit 79 163 212 270 296 294 333 494 862 649 840 804 716
OPM % 12% 16% 17% 20% 22% 18% 16% 21% 27% 20% 21% 21% 21%
2 3 1 6 15 24 28 187 13 13 9 3 9
Interest 16 19 31 37 32 33 28 27 24 16 39 72 72
Depreciation 20 26 50 58 71 76 91 102 118 126 146 144 143
Profit before tax 44 121 132 181 207 208 242 553 733 520 664 591 510
Tax % 32% 33% 28% 33% 31% 33% 33% 20% 25% 26% 25% 26%
30 81 95 121 143 139 162 444 553 387 499 436 375
EPS in Rs 1.50 3.99 4.66 5.57 6.25 5.48 6.37 17.47 22.32 15.59 20.61 17.99 15.48
Dividend Payout % 13% 9% 11% 12% 14% 18% 16% 6% 7% 10% 7% 8%
Compounded Sales Growth
10 Years: 14%
5 Years: 12%
3 Years: 6%
TTM: -14%
Compounded Profit Growth
10 Years: 18%
5 Years: 22%
3 Years: -8%
TTM: -19%
Stock Price CAGR
10 Years: 22%
5 Years: 36%
3 Years: 21%
1 Year: 54%
Return on Equity
10 Years: 18%
5 Years: 19%
3 Years: 17%
Last Year: 15%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 20 20 20 22 23 25 25 25 25 25 24 24 24
Reserves 251 324 405 643 861 1,253 1,398 1,786 2,138 2,506 2,675 3,087 3,187
227 330 412 641 656 978 991 891 849 1,061 923 1,065 736
119 181 270 262 314 382 410 444 672 781 881 830 711
Total Liabilities 617 856 1,107 1,568 1,855 2,639 2,824 3,146 3,683 4,373 4,503 5,006 4,658
245 336 522 523 606 660 700 927 985 1,171 1,330 1,324 1,320
CWIP 92 39 18 35 132 286 333 130 164 211 63 53 84
Investments 51 145 72 89 75 75 506 445 592 597 677 941 987
230 336 494 920 1,042 1,618 1,285 1,644 1,942 2,395 2,433 2,688 2,267
Total Assets 617 856 1,107 1,568 1,855 2,639 2,824 3,146 3,683 4,373 4,503 5,006 4,658

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
51 94 135 144 190 24 227 495 375 280 664 317
-112 -159 -130 -171 -299 -495 -243 -165 -233 -318 -97 -302
43 80 25 86 36 529 -17 -212 -296 151 -519 26
Net Cash Flow -17 16 30 58 -73 58 -33 118 -154 114 48 41

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 37 45 58 122 127 154 122 99 118 136 127 159
Inventory Days 95 75 93 105 132 92 92 103 112 123 100 111
Days Payable 73 79 95 89 116 105 81 96 123 126 126 125
Cash Conversion Cycle 58 41 56 139 142 140 133 105 107 133 102 144
Working Capital Days 57 50 46 124 133 166 132 115 107 141 119 160
ROCE % 13% 24% 22% 20% 17% 13% 12% 16% 26% 16% 20% 17%

Shareholding Pattern

Numbers in percentages

9 Recently
Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
41.98% 41.98% 41.98% 41.93% 42.02% 42.02% 42.02% 41.97% 41.97% 41.96% 38.87% 38.87%
21.38% 23.19% 23.13% 22.35% 23.66% 23.90% 21.35% 21.48% 18.78% 19.57% 20.39% 19.49%
4.34% 3.98% 3.03% 4.32% 4.75% 5.03% 6.68% 7.06% 10.16% 10.70% 14.11% 14.85%
32.30% 30.85% 31.85% 31.40% 29.56% 29.05% 29.95% 29.51% 29.10% 27.77% 26.61% 26.80%
No. of Shareholders 2,16,3852,10,7852,14,5392,16,0551,90,8941,87,7772,01,0542,07,0551,90,6911,82,1421,79,8702,02,198

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls